Rare Lymphomas

Editeur: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
After a decade of tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma, optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors.

En stock

After a decade of tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma, optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors.
ISBN / EAN 9783642395895
Editeur Springer-Verlag Berlin and Heidelberg GmbH & Co. KG